Hereditary Diseases
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 programStudy of Clinical and Molecular Manifestations of Genetic DisordersN/A
Genome & CompanyKorea - Suwon
1 programStudy of Clinical and Molecular Manifestations of Genetic DisordersN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
GeneDxGenome sequencing
Genome & CompanyStudy of Clinical and Molecular Manifestations of Genetic Disorders
Clinical Trials (2)
Total enrollment: 2,200 patients across 2 trials
UW ISeqU: Clinical Impact of Whole-genome Sequencing in Adults
Start: Jul 2026Est. completion: Jul 20321,000 patients
N/AEnrolling By Invitation
Study of Clinical and Molecular Manifestations of Genetic Disorders
Start: Oct 1994Est. completion: Oct 20001,200 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.